BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 25803670)

  • 1. Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women's Health Initiative Observational Study.
    Sullivan SD; Lehman A; Thomas F; Johnson KC; Jackson R; Wactawski-Wende J; Ko M; Chen Z; Curb JD; Howard BV
    Menopause; 2015 Oct; 22(10):1035-44. PubMed ID: 25803670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative.
    LaFleur J; Rillamas-Sun E; Colón-Emeric CS; Knippenberg KA; Ensrud KE; Gray SL; Cauley JA; LaCroix AZ
    Gerontologist; 2016 Feb; 56 Suppl 1(Suppl 1):S78-90. PubMed ID: 26768394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age of menopause and fracture risk in postmenopausal women randomized to calcium + vitamin D, hormone therapy, or the combination: results from the Women's Health Initiative Clinical Trials.
    Sullivan SD; Lehman A; Nathan NK; Thomson CA; Howard BV
    Menopause; 2017 Apr; 24(4):371-378. PubMed ID: 27801706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.
    Crandall CJ; Larson J; Wright NC; Laddu D; Stefanick ML; Kaunitz AM; Watts NB; Wactawski-Wende J; Womack CR; Johnson KC; Carbone LD; Jackson RD; Ensrud KE
    JAMA Intern Med; 2020 Sep; 180(9):1232-1240. PubMed ID: 32730575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.
    Jackson RD; Wactawski-Wende J; LaCroix AZ; Pettinger M; Yood RA; Watts NB; Robbins JA; Lewis CE; Beresford SA; Ko MG; Naughton MJ; Satterfield S; Bassford T;
    J Bone Miner Res; 2006 Jun; 21(6):817-28. PubMed ID: 16753012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
    J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) plasma levels, bone mineral density and risk of hip fracture: a post hoc analysis of the Women's Health Initiative, USA.
    Haring B; Crandall CJ; Carbone L; Liu S; Li W; Johnson KC; Wactawski-Wende J; Shadyab AH; Gass ML; Kamensky V; Cauley JA; Wassertheil-Smoller S
    BMJ Open; 2019 Apr; 9(4):e027257. PubMed ID: 31023762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative.
    Jackson RD; Mysiw WJ
    Semin Reprod Med; 2014 Nov; 32(6):454-62. PubMed ID: 25321423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Age at Menopause With Postmenopausal Bone Mineral Density and Fracture Risk in Women.
    Shieh A; Ruppert KM; Greendale GA; Lian Y; Cauley JA; Burnett-Bowie SA; Karvonen-Guttierez C; Karlamangla AS
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e561-e569. PubMed ID: 34537850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline age and time to major fracture in younger postmenopausal women.
    Gourlay ML; Overman RA; Fine JP; Ensrud KE; Crandall CJ; Gass ML; Robbins J; Johnson KC; LeBlanc ES; Womack CR; Schousboe JT; LaCroix AZ;
    Menopause; 2015 Jun; 22(6):589-97. PubMed ID: 25349960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women.
    Antoniucci DM; Sellmeyer DE; Cauley JA; Ensrud KE; Schneider JL; Vesco KK; Cummings SR; Melton LJ;
    J Bone Miner Res; 2005 May; 20(5):741-7. PubMed ID: 15824846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Barrett-Connor E; Miller PD; Sajjan S; Berger ML; Chen YT
    Osteoporos Int; 2006; 17(4):565-74. PubMed ID: 16392027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary Inflammatory Index, Bone Mineral Density, and Risk of Fracture in Postmenopausal Women: Results From the Women's Health Initiative.
    Orchard T; Yildiz V; Steck SE; Hébert JR; Ma Y; Cauley JA; Li W; Mossavar-Rahmani Y; Johnson KC; Sattari M; LeBoff M; Wactawski-Wende J; Jackson RD
    J Bone Miner Res; 2017 May; 32(5):1136-1146. PubMed ID: 28019686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
    Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
    JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Mineral Density as a Predictor of Subsequent Wrist Fractures: Findings From the Women's Health Initiative Study.
    Crandall CJ; Hovey KM; Andrews CA; Cauley JA; Manson JE; Wactawski-Wende J; Wright NC; Li W; Beavers K; Curtis JR; LeBoff MS
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4315-24. PubMed ID: 26367200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
    Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
    Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal bone changes and incident fractures in diabetic women: a cohort study.
    Khalil N; Sutton-Tyrrell K; Strotmeyer ES; Greendale GA; Vuga M; Selzer F; Crandall CJ; Cauley JA
    Osteoporos Int; 2011 May; 22(5):1367-76. PubMed ID: 20658126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women's Health Initiative hormone therapy trials.
    Lorentzon M; Johansson H; Harvey NC; Liu E; Vandenput L; Crandall CJ; Cauley JA; LeBoff MS; McCloskey EV; Kanis JA
    Osteoporos Int; 2022 Nov; 33(11):2297-2305. PubMed ID: 35833956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between soft drink consumption and osteoporotic fractures among postmenopausal women: the Women's Health Initiative.
    Kremer PA; Laughlin GA; Shadyab AH; Crandall CJ; Masaki K; Orchard T; Snetselaar L; LaCroix AZ
    Menopause; 2019 Nov; 26(11):1234-1241. PubMed ID: 31613830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures.
    Nguyen TV; Jones G; Sambrook PN; White CP; Kelly PJ; Eisman JA
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2709-14. PubMed ID: 7673413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.